SCHEMBL25627063

SCHEMBL25627063

CCN1CCC1COc1nc2c(ccn2CC(C)(C)c2cc3cc[nH]c3nc2OCC2CCN2S(C)(=O)=O)cc1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25613101 0.84 JAK2 (0.34) —
SCHEMBL25627065 0.83 CNR2 (0.31) —
SCHEMBL25613102 0.81 FEN1 (0.31) —
SCHEMBL25613110 0.79 JAK2 (0.38) —
SCHEMBL25613112 0.76 TDP1 (0.35) —
SCHEMBL25625028 0.70 ALOX5AP (0.36) —
SCHEMBL25613103 0.70 CHRNA3 (0.42) —
SCHEMBL24005764 0.69 PIK3CD (0.33) —
SCHEMBL25613114 0.67 CHRNB4 (0.46) —
SCHEMBL24005915 0.65 CHRM3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback